[{"address1": "3 More London Riverside", "city": "London", "zip": "SE1 2AQ", "country": "United Kingdom", "phone": "44 11 7284 2535", "website": "https://www.lumiradx.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.", "fullTimeEmployees": 1210, "companyOfficers": [{"maxAge": 1, "name": "Ms. Veronique  Ameye EMBA, Esq., M.B.A.", "age": 46, "title": "CEO & General Counsel", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dorian  LeBlanc CPA", "age": 48, "title": "CFO & VP of Global Operations", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Colleen  McMillen", "title": "Vice President of Communications", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andy  Ward", "title": "National Sales Director - UK", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Walton DMS", "age": 69, "title": "Chief Commercial Officer", "yearBorn": 1954, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Giffin  Daughtridge", "title": "President of North America Commercial Operations & Global Molecular Solutions", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Melissa  Garcia", "title": "VP & Corporate Counsel", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0096, "open": 0.0097, "dayLow": 0.0096, "dayHigh": 0.011, "regularMarketPreviousClose": 0.0096, "regularMarketOpen": 0.0097, "regularMarketDayLow": 0.0096, "regularMarketDayHigh": 0.011, "beta": 1.713, "forwardPE": -0.045454543, "volume": 2161592, "regularMarketVolume": 2161592, "averageVolume": 18514247, "averageVolume10days": 5359140, "averageDailyVolume10Day": 5359140, "marketCap": 256777984, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 1.33, "priceToSalesTrailing12Months": 2.0296247, "fiftyDayAverage": 0.07858, "twoHundredDayAverage": 0.310815, "currency": "USD", "enterpriseValue": 438120256, "profitMargins": -2.6719, "floatShares": 64024937, "sharesOutstanding": 161024000, "sharesShort": 1430024, "sharesShortPriorMonth": 3501464, "sharesShortPreviousMonthDate": 1700006400, "dateShortInterest": 1702598400, "sharesPercentSharesOut": 0.0045, "heldPercentInsiders": 0.5541, "heldPercentInstitutions": 0.25297, "shortRatio": 0.09, "shortPercentOfFloat": 0.0238, "impliedSharesOutstanding": 185343008, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -338035008, "forwardEps": -0.22, "enterpriseToRevenue": 3.463, "enterpriseToEbitda": -2.445, "52WeekChange": -0.98876405, "SandP52WeekChange": 0.21123838, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "LMDXF", "underlyingSymbol": "LMDXF", "shortName": "LumiraDx Limited", "firstTradeDateEpochUtc": 1616160600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4506d4e1-02c0-328a-a33c-09ede9a2618f", "messageBoardId": "finmb_404719950", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.01, "targetHighPrice": 0.65, "targetLowPrice": 0.65, "targetMeanPrice": 0.65, "targetMedianPrice": 0.65, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 25343000, "totalCashPerShare": 0.079, "ebitda": -179164000, "totalDebt": 460520000, "quickRatio": 0.199, "currentRatio": 0.451, "totalRevenue": 126515000, "revenuePerShare": 0.402, "returnOnAssets": -0.28042, "freeCashflow": -54007876, "operatingCashflow": -129707000, "revenueGrowth": -0.53, "grossMargins": -0.037249997, "ebitdaMargins": -1.4161501, "operatingMargins": -2.31442, "financialCurrency": "USD", "trailingPegRatio": null}]